Your browser doesn't support javascript.
loading
A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan.
Takanashi, Satoshi; Kaneko, Yuko; Kawahito, Yutaka; Kida, Takashi; Sugihara, Takahiko; Kojima, Toshihisa; Harada, Ryozo; Ishitoku, Michinori; Hirata, Shintaro; Hashimoto, Motomu; Hidaka, Toshihiko; Abe, Asami; Ishikawa, Hajime; Ito, Hiromu; Kishimoto, Mitsumasa; Matsui, Kazuo; Matsui, Toshihiro; Matsushita, Isao; Onishi, Akira; Morinobu, Akio; Nishida, Keiichiro; Asai, Shuji; Tanaka, Eiichi; Harigai, Masayoshi; Kojima, Masayo.
Affiliation
  • Takanashi S; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan.
  • Kaneko Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan.
  • Kawahito Y; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan.
  • Kida T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan.
  • Sugihara T; Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Japan.
  • Kojima T; National Hospital Organization Nagoya Medical Center, Orthopaedic Surgery and Rheumatology, Japan.
  • Harada R; Department of Orthopaedic Surgery, Kurashiki Sweet Hospital, Japan.
  • Ishitoku M; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
  • Hirata S; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Japan.
  • Hashimoto M; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan.
  • Hidaka T; Miyazaki-Zenjinkai Hospital, Japan.
  • Abe A; Department of Rheumatology, Niigata Rheumatic Center, Japan.
  • Ishikawa H; Department of Rheumatology, Niigata Rheumatic Center, Japan.
  • Ito H; Kurashiki Central Hospital, Japan.
  • Kishimoto M; Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Japan.
  • Matsui K; Department of Rheumatology, Teine Keijinkai Hospital, Japan.
  • Matsui T; Department of Rheumatology Research, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan.
  • Matsushita I; Department of Rehabilitation Medicine, Kanazawa Medical University, Japan.
  • Onishi A; Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Japan.
  • Morinobu A; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Japan.
  • Nishida K; Department of Orthopaedic Surgery, Science of Functional Recovery and Reconstruction, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.
  • Asai S; Department of Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Japan.
  • Tanaka E; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Japan.
  • Harigai M; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Japan.
  • Kojima M; Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Japan.
Intern Med ; 2024 May 02.
Article in En | MEDLINE | ID: mdl-38692915
ABSTRACT
Objectives We investigated the current perspectives regarding the management of late-onset rheumatoid arthritis (LORA) among rheumatologists in clinical practice. Methods This study was performed in October 2021, and included 65 rheumatologists certified by the Japan College of Rheumatology, who were administered questionnaires (including multiple choice and descriptive formulae) regarding the management of LORA. We aggregated and analyzed the responses. Results All 65 rheumatologists responded to the survey; 47 (72%) answered that >50% of newly diagnosed patients were aged ≥65 years, 42 (65%) answered that achievement of remission or low disease activity was the treatment goal, and 40 (62%) considered patient safety to be the highest priority. Most rheumatologists are concerned about the management of conditions other than RA, such as comorbidities, financial constraints, and life circumstances that interfere with standard or recommended treatment implementation. Conclusion This preliminary survey highlighted various rheumatologists' perspectives regarding the management of LORA.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2024 Document type: Article Affiliation country: